menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

RFK Jr. further limits COVID-19 vaccines

2 1
28.08.2025
*{box-sizing:border-box}body{margin:0;padding:0}a[x-apple-data-detectors]{color:inherit!important;text-decoration:inherit!important}#MessageViewBody a{color:inherit;text-decoration:none}p{line-height:inherit}.desktop_hide,.desktop_hide table{mso-hide:all;display:none;max-height:0;overflow:hidden}.image_block img div{display:none}sub,sup{font-size:75%;line-height:0}#converted-body .list_block ol,#converted-body .list_block ul,.body [class~=x_list_block] ol,.body [class~=x_list_block] ul,u .body .list_block ol,u .body .list_block ul{padding-left:20px} @media (max-width:620px){.desktop_hide table.icons-outer{display:inline-table!important}.image_block div.fullWidth{max-width:100%!important}.mobile_hide{display:none}.row-content{width:100%!important}.stack .column{width:100%;display:block}.mobile_hide{min-height:0;max-height:0;max-width:0;overflow:hidden;font-size:0}.desktop_hide,.desktop_hide table{display:table!important;max-height:none!important}.reverse{display:table;width:100%}.reverse .column.first{display:table-footer-group!important}.reverse .column.last{display:table-header-group!important}.row-6 td.column.first .border,.row-8 td.column.first .border{padding:5px 5px 15px 25px}.row-10 td.column.last .border,.row-6 td.column.last .border,.row-8 td.column.last .border{padding:5px 20px 25px 5px}.row-10 td.column.first .border{padding:5px 5px 15px 25px;border-bottom:15px solid transparent}} Click in for more news from The Hill

{beacon}

Health Care

Health Care

 

The Big Story

RFK further limits COVID-19 shot to high-risk groups

The U.S. Food and Drug Administration (FDA) approved updated versions of Pfizer and Moderna’s COVID-19 vaccines, but limited who is eligible to receive the shots.

© AP

Now, the jabs are approved for seniors and people with at least one underlying condition, putting them at a high risk of severe infection ahead of the upcoming respiratory viral season.

Moderna said the FDA greenlit its updated Spikevax vaccine, which offers protection against the LP.8.1 variant of the virus. Pfizer’s updated Comirnaty shot, which also provides protection against the variant, was approved by the agency, the company said in a statement.

Pfizer’s jab was approved for adults 65 and older, as well as people between ages 5 and 64 who have at least one underlying health risk that puts them at greater risk of developing severe outcomes from the virus.

These approvals coincided with Health and Human Services Secretary (HHS) Robert F. Kennedy Jr. Announcing that the FDA was rescinding the emergency use authorizations (EUA) for COVID-19 vaccines, removing another potential avenue through which health individuals may have been able to access the shots.

  • Under the EUA, children and adults could access COVID-19 vaccines regardless of their health status.

  • The EUAs were granted to the COVID-19 vaccines prior to them receiving full approval from the FDA.

  • EUAs are granted to medical products by the FDA when no approved, alternative product is available and the agency has determined that the potential benefits outweigh potential risks.

Despite these narrowed approvals and pathways to access, it remains unclear whether all individuals will be able to get COVID-19 vaccines this upcoming respiratory viral season.

In his announcement Wednesday, Kennedy said, “These vaccines are available for all patients who choose them after consulting with their doctors.”

 

Welcome to The Hill’s Health Care newsletter, we’re Joseph Choi and Alejandra O'Connell-Domenech — every week we follow the latest moves on how Washington impacts your health.

Correction: The principal deputy assistant........

© The Hill